Fresenius Medical Care AG (FMS) stock
Close on Nov 11, 2026Market cap $6.21BP/E –Yield –
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $6.21B
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Diluted shares
- 268M
Trading
- Previous close
- $22.74
- Open
- $22.63
- Day's range
- $21.91 – $22.70
- Volume
- 5,971,317
- Average volume (20 days)
- 1,657,117
- Beta (5 years)
- 0.45
- 52-week range
- $20.02 – $26.42
- RSI (14 days)
- 47.4
- Volatility (1 year)
- 30.8%
- Relative volume
- 6.64×
- WACC
- 7.4%
Market cap history
Month-end market cap since 2009, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | FMS | S&P 500 | Difference | FMS per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +5.5% | -2.4% | +7.9 pts | ||
| 3 months | -6.9% | -1.2% | −5.8 pts | ||
| Year to date | -3.0% | +12.3% | −15.2 pts | ||
| 1 year | -3.6% | +12.4% | −16.1 pts | ||
| 3 years | +42.3% | +78.8% | −36.5 pts | +12.5% | +21.4% |
| 5 years | -22.6% | +75.2% | −97.7 pts | -5.0% | +11.9% |
| 10 years | -30.2% | +311.1% | −341.3 pts | -3.5% | +15.2% |
Fifteen years at a glance
Fiscal years 2011 to 2025, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Fresenius Medical Care filed with the SEC as exhibits to Form 8-K or 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
About Fresenius Medical Care
Services-Misc Health & Allied Services, NEC
Fresenius Medical Care is a healthcare company specializing in dialysis and renal care. The enterprise operates primarily across two operational business segments: Care Delivery and Care Enablement, while also engaging in value-based care initiatives. Through these segments, the organization provides comprehensive healthcare services as well as specialized healthcare products. Its clinical activities encompass dialysis care and associated renal treatments, while product offerings consist of dialysis machinery, healthcare equipment, and related supplies. Key customers include dialysis patients, healthcare providers, and public healthcare programs, notably U.S. Medicare and Medicaid.
Company profile, executives and historyFresenius Medical Care stock: common questions
What is Fresenius Medical Care's stock price?
FMS closed at $22.22 on Nov 11, 2026, down 2.29% on the day. Over the past 52 weeks it traded between $20.02 and $26.42.
What is Fresenius Medical Care's market cap?
Fresenius Medical Care was worth $6.21B at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
Does Fresenius Medical Care pay a dividend?
No. Fresenius Medical Care has not paid a cash dividend over the last twelve months.
How has FMS stock performed over the past year?
Including dividends, FMS returned -3.6% over the past year, against +12.4% for the S&P 500.
Who are Fresenius Medical Care's competitors?
Companies most similar to Fresenius Medical Care by business, industry and size include DVA, SHC, AGL, PGNY, VMD.
See a number that looks wrong?